⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19025852 | 0.81 | — | — | |
| SCHEMBL9620893 | 0.79 | — | — | |
| SCHEMBL1868014 | 0.78 | — | — | |
| SCHEMBL394425 | 0.77 | RIPK1 (0.33) | — | |
| SCHEMBL9586177 | 0.77 | — | — | |
| SCHEMBL8356703 | 0.77 | — | — | |
| SCHEMBL1868845 | 0.75 | TLR8 (0.32) | — | |
| SCHEMBL29020377 | 0.74 | SLC6A2 (0.30) | — | |
| SCHEMBL2698490 | 0.74 | SLC6A2 (0.30) | — | |
| SCHEMBL27337058 | 0.74 | SLC6A2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731954-B2 | Histone demethylase inhibitors | CELGENE QUANTICEL RES INC (US) | 2023-08-22 | — | — | US | claimed |
| US-20210238161-A1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RESEARCH, INC. (US) | 2021-08-05 | — | — | US | claimed |
| US-11001568-B2 | Histone demethylase inhibitors | CELGENE QUANTICEL RESEARCH, INC. (US) | 2021-05-11 | — | — | US | claimed |
| US-20200157077-A1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RESEARCH, INC. (US) | 2020-05-21 | — | — | US | claimed |
| EP-3397617-A1 | HISTONE DEMETHYLASE INHIBITORS | Celgene Quanticel Research, Inc. (US) | 2018-11-07 | — | — | EP | claimed |
| US-10059687-B2 | Histone demethylase inhibitors | CELGENE QUANTICEL RESEARCH, INC. (US) | 2018-08-28 | — | — | US | claimed |
| WO-2017117154-A1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RESEARCH, INC. (US) | 2017-07-06 | — | — | WO | claimed |
| US-20170183325-A1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RESEARCH, INC. | 2017-06-29 | — | — | US | claimed |
| CN-104203936-B | Metalloenzyme inhibitor compounds | 威尔金制药有限公司 | 2017-04-19 | — | — | CN | claimed |
| EP-2190054-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR SECONDARY BATTERY AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2016-10-26 | — | — | EP | claimed |
| WO-2005005382-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | CYTOKINETICS, INC. (US) | 2005-01-20 | — | — | WO | claimed |
| EP-1343561-A1 | SERINE PROTEASE INHIBITORS | Tularik Limited (GB) | 2003-09-17 | — | — | EP | claimed |
| WO-2002047762-A1 | SERINE PROTEASE INHIBITORS | TULARIK LIMITED (GB) | 2002-06-20 | — | — | WO | claimed |
| US-4512989-A | IMIDOESTERS OR IMIDOTHIOESTERS | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 1985-04-23 | — | — | US | claimed |
| CN-117925215-A | Electrochromic composition and electrochromic device | 泰盈光电股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240085753-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC DEVICE | TAI YING OPTRONICS CO., LTD. (TW) | 2024-03-14 | — | — | US | disclosed |
| EP-3595072-B1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTIC SOLUTIONS, NON-AQUEOUS ELECTROLYTIC SOLUTION, AND ELECTRICAL STORAGE DEVICE | SUMITOMO SEIKA CHEMICALS (JP) | 2023-10-04 | — | — | EP | disclosed |
| EP-0075737-A1 | N-Chlorocarbonyl-amino-acid esters, process for their preparation and their use | Degussa Aktiengesellschaft (DE) | 1983-04-06 | — | — | EP | disclosed |
| EP-0067698-A2 | Optically active 1-aromatic-group-substituted-1-alkanones and methods for their manufacture | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1982-12-22 | — | — | EP | disclosed |
| EP-0000220-A1 | Dihydrouracils, process for their preparation and pharmaceuticals containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-01-10 | — | — | EP | disclosed |